Bertrand William C JR

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$343,823.60
Insider Sells Quantity
18
Insider Sells Sum
$195,473.41

Insider Activity of Bertrand William C JR

According to the SEC Form 4 filings, Bertrand William C JR, being in a position of

  1. Chief Operating Officer at Adaptimmune Therapeutics plc,
    оver the last 12 months, has bought 0 shares, and sold 32818 shares for $24,236,
    over all time since 2019-01-14, has bought 207000 shares for $143,824, and sold 84312 shares for $195,473.

The largest purchase of all time was on 2015-12-17 and amounted to 10000 shares of Ardelyx, Inc. for $200,000.

The largest sale of all time was on 2019-01-14 and amounted to 4542 shares of Adaptimmune Therapeutics plc for $24,388.

Biography of Bertrand William C JR

No biography is available at this moment.

2024-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
18,908
0.0078%
$0.67$12,725+52.45%
2024-01-16SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,681
0.0023%
$0.79$3,698+53.5%
2024-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
5,220
0.0024%
$0.85$4,458+32.19%
2024-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,009
0.0017%
$0.84$3,354+26.39%
2023-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,440
0.0029%
$1.86$8,250-47.31%
2023-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,973
0.0028%
$1.71$8,484-49.29%
2023-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
3,843
0.0023%
$1.75$6,713-48.1%
2023-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
3,584
0.0021%
$1.69$6,071-47.5%
2022-01-18SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,368
0.0029%
$3.19$13,942-40.52%
2022-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
2,248
0.0015%
$3.54$7,967-46.49%
2022-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
3,770
0.0024%
$3.56$13,409-48.88%
2022-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
3,490
0.0024%
$4.06$14,184-52.08%
2021-07-02SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,375
0.0028%
$4.26$18,659-18.56%
2021-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
2,234
0.0015%
$6.15$13,744-15.45%
2021-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
3,499
0.002%
$5.33$18,642-16.14%
2020-12-14PurchaseAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
207,000
0.0227%
$0.69$143,824+23.78%
2020-01-14SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
2,397
0.0025%
$5.13$12,308+28.47%
2020-01-06SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
3,731
0.003%
$1.20$4,477+310.74%
2019-01-14SaleAdaptimmune Therapeutics plc
ADAP
Chief Operating Officer
4,542
0.0043%
$5.37$24,388-35.9%
2015-12-17PurchaseArdelyx, Inc.
ARDX
director
10,000
0.0448%
$20.00$200,000-47.38%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.